2,3,4,5-tetrahydroxypentanal has been researched along with Cardiomyopathies in 2 studies
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, GR | 1 |
| Zhang, C | 1 |
| Yang, HX | 1 |
| Sun, JH | 1 |
| Zhang, Y | 1 |
| Yao, TT | 1 |
| Li, Y | 1 |
| Ruan, L | 1 |
| An, R | 1 |
| Li, AY | 1 |
| Nguyen, MN | 1 |
| Su, Y | 1 |
| Kiriazis, H | 1 |
| Yang, Y | 1 |
| Gao, XM | 1 |
| McMullen, JR | 1 |
| Dart, AM | 1 |
| Du, XJ | 1 |
2 other studies available for 2,3,4,5-tetrahydroxypentanal and Cardiomyopathies
| Article | Year |
|---|---|
Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4/MyD88/NF-κB signaling pathway.
Topics: Animals; Biomarkers; Biopsy; Cardiomyopathies; Cytokines; Disease Susceptibility; Echocardiography; | 2020 |
Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β
Topics: Amino Sugars; Animals; Cardiomyopathies; Disease Models, Animal; Fibrosis; Galectin 3; Genetic Predi | 2018 |